期刊文献+

右心功能、脑钠肽及心肌肌钙蛋白Ⅰ对非高危急性肺栓塞危险分层的临床价值 被引量:12

Clinical value investigation of right ventricular function,brain natriuretic peptide and troponin on risk stratification in non high risk patient with acute pulmonary embolism
在线阅读 下载PDF
导出
摘要 目的探讨右心功能、脑钠肽(BNP)及心肌肌钙蛋白I(cTnI)对非高危急性肺栓塞(APE)患者危险分层的临床价值。方法入选2010年1月~2013年6月确诊的非高危APE患者60例,根据有无右心功能不全及血浆cTnI、BNP水平将人选患者分为3组。中高危组(15例):右心功能不全,cTnI≥0.1μg/L和/或BNP≥100ng/L;中低危组(30例):或存在右心功能不全,或存在cTnI≥0.1μg/L、BNP≥100ng/L中的至少一项;低危组(15例):右心功能正常,cTnI〈0.1μg/L且BNP〈100ng/L。分析右心功能、cTnI、BNP水平与APE患者危险分层和临床预后的关系。结果中高危组、中低危组、低危组的30d临床不良事件发生率分别为33.3%、20.0%、0.0%,病死率分别为13.3%、6.7%、0.0%,差异有统计学意义(P〈0.05);中高危组和中低危组的cTnI、BNP水平明显高于低危组,中高危组的cTnI、BNP水平与中低危组相比亦明显增高,差异均有统计学意义(P〈0.05)。结论右心功能及血浆cTnI、BNP水平在APE患者危险分层中具有重要的临床价值。 Objective To explore the clinical value of right ventricular function,brain natriuretic peptide (BNP)and cardiac troponin I (cTn I ) on risk stratification in non high risk patients with acute pulmonary embolism(APE). Methods 60 patients with non high risk APE diagnosed from January 2010 to June 2013 were selected and divided into intermediate-high risk group (15 cases), intermediate-low risk group (30 cases) and low-risk group (15 cases) based on right ventricular function, cTn I and BNP level. Intermediate-high risk group: fight ventricular dysfunction (RVD), one of the cTn I ≥0.1 μg/L and BNP ≥ 100 ng/L at least; intermediate-low risk group: RVD or cTn I ≥0.1 μg/L and/or BNP≥ 100 rig/L; low-risk group:normal right ventricular function, cTn I 〈0.1 μg/L and BNP〈IO0 ng/L.Right ventricu- lar function, plasma BNP and cTn I level were detected. Relationship among right ventricular function, BNP, cTn I level and risk stratification of APE patient, clinical outcome were analyzed. Results Incidence rate of clinical adverse event at 30 days in intermediate-high risk group, intermediate-low risk group and low-risk group was 33.3%, 20.0%, 0.0% respectively,mortality rate of intermediate-high risk group, intermediate-low risk group and low-risk group was 13.3%, 6.7%, 0.0% respectively, with statistical differences (P 〈 0.05). cTn I and BNP level of intermediate-high risk group and intermediate-low risk group was significantly higher than that of low-risk group respectively, cTn I and BNP level of intermediate-high risk group was significantly higher than that of intermediate-low risk group respectively, with statistical differences (P 〈 0.05). Conclusion Right ventricular function, cTn I and BNP level have important clinical value for risk stratification in the non high risk patients with acute pulmonary embolism.
出处 《中国医药导报》 CAS 2015年第14期8-10,14,共4页 China Medical Herald
基金 国家自然科学基金资助项目(81273948) 河南省高校科技创新团队支持计划(13IRTSTHN012)(C20130050)
关键词 急性肺栓塞 脑钠肽 心肌肌钙蛋白I 右心功能 危险分层 Acute pulmonary embolism Brain natriuretic peptide Cardiac troponin I Right ventricular function Riskstratification
  • 相关文献

参考文献14

  • 1Torbicki A, Perrier A, Konstantinides S, et al. Guidehnes on the diagnosis and management of acute pulmonary em- bolism:the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)[J]. Eur Heart J,2008,29 (18):2276- 2315.
  • 2急性肺血栓栓塞症诊断治疗中国专家共识[J].中华内科杂志,2010,49(1):74-81. 被引量:404
  • 3刘君明.64层螺旋CT肺血管造影在肺动脉栓塞中的诊断价值[J].中国现代医生,2013,51(24):79-80. 被引量:10
  • 4Jaff MR,McMurtry MS,Archer SL,et al. Management of massive and submassive pulmonary embolism,iliofemoral deep vein thrombosis,and chronic thromboembolic pul- monary hypertension: a scientific statement from the Amer- ican Heart Association[J]. Circulation,2011,123(16) : 1788- 1830.
  • 5巫少荣,郭军,李自成.急性肺动脉栓塞125例临床分析[J].临床心血管病杂志,2012,28(5):377-378. 被引量:19
  • 6Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism:the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the Euro- pean Society of Cardiology (ESC)Endorsed by the Euro- pean Respiratory Society (ERS) [J]. Eur Heart J, 2014,35 (43) : 3033-3073.
  • 7Sanchez O, Trinquart L, Colombet I, et al. Prognostic value of right ventricular dysfunction in patients with haemodynam- ically stable pulmonary embolism:a systematic review[J]. Eur Heart J,2008,29(12) : 1569-1577.
  • 8Kucher N, Rossi E, De Rosa M, et al. Prognostic role of e- chocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher [J]. Arch Intern Med,2005,165(15) : 1777-1781.
  • 9Klok FA,Mos IC,Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in pa- tients with pulmonary embolism:a systematic review and meta-analysis [J]. Am J Respir Crit Care Med,2008,178 (4) :425-430.
  • 10Jim6nez D, Uresandi F, Otero R,et al. Troponin-based risk stratification of patients with acute nonmassive pul- monary embolism:systematic review and meta-analysis[J]. Chest, 2009,136(4) : 974-982.

二级参考文献73

  • 1荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 2贾卫滨,张春秀,顼志敏.中国肺动脉栓塞误诊近四年文献分析[J].中华心血管病杂志,2006,34(3):277-280. 被引量:105
  • 3邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 4Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
  • 5Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
  • 6PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
  • 7Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
  • 8Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
  • 9Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
  • 10Dalla-Volta S, Palla A, Santolicandro A, et al. PALMS 2: aheplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520-526.

共引文献436

同被引文献113

引证文献12

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部